




 Antibiotic resistance has become a major problem in public health. This resistance has 
been a growing issue due to years of inappropriate use of antibiotics. Hospitals are the most 
prevalent settings where bacterial infections occur related to antibiotic resistance. Some hospital 
infections cannot be treated because the bacteria are resistant to all currently available 
antibiotics.  However, a program has evolved that helps to combat this. 
 Antibiotic stewardship fights the inappropriate use of antibiotics.  The Antibiotic 
stewardship program (ASP) uses two main interventions: Prospective audit with intervention and 
feedback, and Formulary restriction and preauthorization. These are two ways to monitor 
prescribing by health care providers which saves antibiotic availability. 
 As antibiotic resistance is a public health issue, the core functions of the discipline are 
utilized: assessment, policy development, and assurance. Assessment analyzes the need for the 
program, and where they should be delivered; policy proposes, from the assessment, plans and 
processes; and assurance makes sure that what was proposed is what is delivered. The Centers 
for Disease Control and Prevention (CDC) has developed a number of website programs that 
analyze the antibiotic resistance problem in this nation. Other CDC websites introduce and 
explain how an ASP can fight the development of antibiotic resistance. National policies are also 
being proposed for this issue. 
 ASPs are needed in all hospitals. The problem of antibiotic resistance is not going away 
and actions must be taken. Public health is in a unique position to address this problem, and the 
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INTRODUCTION and BACKGROUND 
 Antibiotic resistance is a critical health crisis, especially in medical settings, where 
analysis by the core functions of public health can develop policies and programs to confront the 
issue. The Institute of Medicine describes the core functions of public health as Assessment, 
Policy Development, and Assurance (Turnock, 2012). These three main tenets of the discipline 
are designed to identify current issues affecting public health, form policies to deal with these 
problems, and implement programs to address the issues, and analyze results of the program to 
determine the success of the intervention.  
 Currently, the Centers for Disease Control and Prevention (CDC) estimates that “over 
two million patients are infected with antibiotic resistant organisms, resulting in approximately 
23,000 deaths annually” (Antibiotic Resistance Threats in the United State, 2013). However, 
from the time of the discovery of penicillin in 1928, bacteria steadily have become more resistant 
(Dellit, T. H., Owens R. C., McGowan J.E. Jr, Gerding, D.N., Weinstein, R.A., Burke, J.P., . . . 
Hooton TM, 2007). A myriad of antibiotics have been discovered since penicillin, each 
eventually becoming less capable of treating bacterial infections. This cycle continues as each 
new antibiotic becomes less and less effective. In some cases, infections are not able to be treated 
at all. With a paucity of antimicrobials being produced by pharmaceutical companies, and very 
few being approved by the Food and Drug Administration (FDA), the situation is even dire. 
 Antibiotic resistance is caused ultimately by the overuse of antimicrobials (Dellit et al., 
2007). An estimated 20% to 50% of all hospitalized patients are inappropriately prescribed 
antibiotics (Carling, P., Fung P, Killion A., Terrin, N. & Barza, N., 2003; LaRocco, A.2003). 
With this overprescribing, bacteria become more resistant to antibiotics. The problem is there are 
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only a few antibiotics available to treat infections (Core Elements of Hospital Antibiotic 
Stewardship Program, 2015). Not only that, with this increased antibiotic use, there are fewer 
antibiotics to treat the more difficult infections. 
 One result of excessive antimicrobial usage is a gastrointestinal disease called 
Clostridium difficile infection (CDI). This disease is caused by the bacteria C. difficile 
(Antibiotic Resistance Threats in the United States, 2013). CDI is a debilitating illness causing 
severe diarrhea and colitis (Antibiotic Resistance Threats in the United States, 2013). This 
disease produces high morbidity and mortality with 250,000 hospitalized cases in the U.S. 
annually with 14,000 deaths annually (Antibiotic Resistance Threats in the United States, 2013). 
Antibiotics have been around for nearly a century. Cures of many diseases occurred as 
these “miracle drugs” eliminated the fear of many infections. Now, however, that has been 
challenged by bacteria developing resistance to antibiotics, some to the extent that the infection 
is untreatable. There is a public health need for the control of this problem. Antibiotic 
stewardship, a program to eliminate inappropriate use of antibiotics, can be utilized to combat 
antibiotic resistance. Physicians, other healthcare providers, and administration must realize the 
valuable contribution an antibiotics stewardship program can add to reduce antibiotic resistance 
in their hospital, and save patient lives. The purpose of this paper is to discuss assessment of the 
amount of antibiotic resistance in the hospital, development of policies to decrease the resistance 
by utilizing antibiotic stewardship, and the result of outcomes to insure the success of the 
antibiotic stewardship intervention.   
Antibiotic Stewardship Program 
 The increase in morbidity and mortality from bacterial resistance to antibiotics is a 
growing public health crisis. With the rising rate of multidrug resistant organisms (MDRO), 
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increased antibiotic use, and increased CDI and adverse events, the threats posed by antibiotic 
resistance are significant for hospitals, communities, and individuals. There is a reality that must 
be faced. With increased unnecessary use of antibiotics, the faster they lose their effectiveness 
(White House Forum on Antibiotic Stewardship Convenes Government and Private Sector 
Leaders Committed to Improving Antibiotic Prescribing, 2015). Add to this, the reality that 
fewer new antibiotics are being produced that any overuse or misuse of antibiotics brings the 
world closer to the point where the simplest of infections may not be treatable. However, the 
greatest concern is not the evolution of bacteria—it is the inaction of people. 
 An action that needs to be implemented in all medical facilities where antibiotics are 
prescribed is an antibiotic stewardship program (ASP). In this program, smart policies and 
effective partnerships are essential and guide effective use of antibiotics. With the aid of these 
partnerships, the goal of the ASP is “to optimize clinical outcomes while minimizing unintended 
consequences of antimicrobial use including toxicity, the selection of pathogenic organisms 
(i.e.—C. difficile) and the emergence of resistance” (Dellit et al.2007). Guidance is needed by 
the ASP to reach these goals, and enhance patient outcomes.  
 An ASP must have commitment from leadership (CEO, medical officers) to procure 
human, financial, and information technology (IT) resources. Without this, they will ultimately 
fail. The program takes a team effort. An infectious disease physician is required for his or her 
expertise, and is accountable for the program’s outcome. Another core team member includes a 
clinical pharmacist with infectious diseases training. This member’s knowledge of antibiotics 
and medication therapy management is of great value. Other team members (not all are 
necessary, but highly recommended) include a clinical microbiologist, IT specialist, infection 
control preventionist, and a hospital epidemiologist (Dellit et al., 2007). This group is tasked 
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with a difficult problem. Prescribing errors in the hospital are quite common. For example, 
antibiotics are commonly and incorrectly ordered for lung infections which are often due to a 
virus rather than bacteria. Another is the unnecessary treatment of urinary tract infections (UTI). 
One of every three UTIs are overprescribed for unnecessary antimicrobial treatment. These 
antibiotics become at risk for resistance and could be saved for more critical, life-threatening 
infections (MacDougal, C. & Polk, R.E, 2005). These examples show how the prescribing of 
unnecessary antibiotic can occur. 
 Overprescribing of antibiotics can put patients at risk for CDI; however, by reducing 
hospital antibiotic use by 5% can lead to a 26% reduction in CDI (Making Health Care Safer, 
2015). Also, patients treated with powerful, broad-spectrum antibiotics are three times more 
likely to acquire another more resistant bacterial infection (Chan R., Hemeryck, L., O’Regan, 
M., Clancy L. & Feely, J.,1995). The more infections are treated with more powerful, and many 
times unnecessary, antibiotic therapy, the more patients become vulnerable to resistant bacteria. 
Two Major Intervention Types by ASP 
Antibiotic stewardship utilizes two major active interventions in the hospital to reduce 
inappropriate use of antimicrobials: prospective audit with intervention and feedback and 
formulary restriction and preauthorization. 
 Prospective Audit with Intervention and Feedback 
 First, there is the prospective audit with intervention and feedback. This intervention 
allows prescribing physicians access to the entire antibiotic formulary. However, if the infectious 
disease physician or clinical pharmacist from the ASP detects inappropriate antibiotic treatment 
using computer software, they can correct the treatment, and have the opportunity to interact 
with the prescriber (Dellit, et al., 2007). A hospital utilizing the prospective audit and feedback 
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intervention for over a 7-year period showed a 22% decrease in intravenous antibiotic therapy, 
decreased CDI, and reduced hospital-acquired infections (HAI) caused by Enterobacteriacea 
(Carling et al., 2003). Another study by Solomon and colleagues (Solomon, D.H., Van Houton, 
L. & Glynn, R.J., 2001) displayed a 37% reduction in days of unnecessary treatment by 
levofloxacin and ceftazidime, including a decrease in the start of other antibiotics. A smaller 
hospital, without the resources for a full-scale ASP, showed a 69% compliance with the ASP 
guidelines set by the hospital. This down-sized program resulted in an annual savings of 
$177,000 for antimicrobial expenditure (Levin, P.D., Idress, S., & Sprung, C.L, 2012). Another 
study (Fraser, G.L., Stogdill, P., Dickens, J.D., Wennberget, D.E., Smith, R.P. & Prato,, S. 1997) 
in a hospital utilizing prospective audit with feedback and intervention was conducted to analyze 
the acceptance of suggestions from the ASP and acceptance of those suggestions. In this study, 
85% of the suggestions from the ASP were implemented. Also, there were 1.6 fewer days of 
intravenous therapy with no impact on clinical outcomes compared to controls. There was also a 
saving of $400 per patient. 
Formulary Restriction and Preauthorization 
 The second type of intervention is formulary restriction and preauthorization. This 
antibiotic stewardship strategy limits the use of certain antimicrobials without preauthorization 
from an infectious disease doctor or pharmacist on the stewardship committee. In most hospitals, 
there is a committee that evaluates antibiotics for inclusion on the hospital formulary. 
Therapeutic efficacy, toxicity, cost, and redundancy of agents are considered as criteria for 
inclusion as acceptable antimicrobials for use. This more restrictive intervention has proven to be 
more effective at reducing the use of antibiotics. A study by Philmon and colleagues (Philmon, 
C., Smith, T., Williamson, S., & Goodman, E. 2006) tested the cost effectiveness of an ASP. In 
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the almost 3-year study, a cost savings of nearly 1.9 million dollars was found due to the 
stewardship program. Recommendations by ASPs were also shown to increase antimicrobial 
appropriateness, clinical cure, and economic outcomes due to Formulary Restriction and 
Preauthorization (Dellit et al., 2007). However, in many other studies, (Quale, J., Landman, D., 
Aurina, G., Atwood, E., DiTora, V., & Patel, K.,1996; White, A.C., Atmar, R.L., Wilson, J., 
Cate, T.R., Stager, C.E., & Greenberg, S.B.,1997), this stewardship strategy showed an initial 
benefit; however, as the use of the restricted antibiotic lessened, the use of a new, preferred 
antibiotics emerged with the concomitant increased resistance (White, A.C. et al.,.1997). This 
phenomenon is known as “squeezing the balloon” where the restricted antibiotic becomes less 
resistant, but the “replacement” antibiotic becomes resistant (Burke, 1998). 
Supplemental Antibiotic Stewardship Strategies 
 In addition to the two main active strategies for antibiotic stewardship described above, 
there are several supplemental intervention strategies. While these interventions complement the 
main strategies, they are more passive and less effective as the sole intervention (Dellit et al., 
2007). 
 Education is an effective and essential intervention for an ASP. These activities are 
essential to an ASP and include conference presentations, hospital staff presentations, and 
email alerts. However, education alone without one of the active strategies is a 
marginally successful intervention (Dellit et al., 2007). 
 Guidelines and clinical pathways for antibiotic stewardship create standards for 
antibiotic treatment. These standards use evidence-based practice to make antibiotic 
treatment decisions (Dellit et al., 2007). The use of the interventions can be effective 
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despite physician resistance (Dellit et al.). Incorporating local patterns of antibiotic 
resistance can improve antimicrobial use and patient outcomes (Dellit et al.). 
 Antimicrobial cycling and scheduled antimicrobial switching is an ineffective, yet 
often employed secondary strategy of antibiotic stewardship. With the proper 
implementation of this intervention, certain antibiotics are removed from the antibiotic 
formulary and may not be used without preauthorization. Most studies show that as an 
antibiotic is removed, another must be used, with eventual bacterial resistant to the new 
antimicrobial (Burke, 1998). An antibiotic switch is unlikely to reduce resistance. 
 Combination therapy is the prescribing of two or more antimicrobials to cover all 
possible bacteria causing an infection. This strategy can be used for a variety of reasons 
including empirical therapy, improved clinical outcomes, and the prevention of antibiotic 
resistance. Serious infections require complete coverage of all infection types. However, 
many times, therapy is redundant and unnecessary (Dellit, et al., 2007).. Although, 
combination therapy may be necessary for empiric treatment, routine use of combination 
therapy is not recommended as an antibiotic stewardship strategy. 
 Streamline or de-escalation of therapy is the re-evaluation of antibiotic therapy when 
microbiological therapy and antibiotic susceptibilities are available. This intervention 
aids in the judicious use of antibiotics. Empiric therapy is needed to optimize treatment 
for many infections; however, it also promotes the selection of resistant pathogens. This 
can be combated when culture collected from tissue or body fluids, and/or antibiotic 
sensitivities are available. Treatment can often be streamlined or de-escalated, especially 
when broad-spectrum antibiotics are initially used (Kollef, M.H. & Kollef, K.E., 2005). 
Cultures and sensitivities are usually available 48 to 72 hours after they are collected. A 
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study by Briceland and colleagues (Briceland, L.L., Nightingale, C.H., Quintiliani, R., 
Cooper, B.W., & Smith, K.S.,1988 ) showed that reevaluating therapy during this time 
frame by a physician or another member of the ASP led to a 54% increase in 
recommendation to change therapy and resulted in an annual savings of over $107,000. 
 Dose optimization individualizes antibiotic therapy to improve treatment. This 
optimization accounts for individual characteristics (i.e.—age, renal function, weight), 
infected organ (i.e.—urine, pneumonia, skin), and pharmacokinetic and 
pharmacodynamic characteristics of the drug (Dellit et al., 2007). All of these are taken 
into consideration when beginning therapy. This will optimize the accuracy of treatment 
by use of the proper antibiotic and correct dosage. 
 Conversion from parenteral to oral therapy is the effective and timely shift of 
antibiotic treatment from intravenous to oral delivery of the drug. This modification can 
result in reduced length of hospital stay, health care costs, and complications that may 
occur from parenteral (intravenous) treatment. This switch can only occur if certain 
clinical criteria are met. Nevertheless, it has been shown in studies that this conversion 
can significantly reduce costs with no effect on health outcomes (Chan R.et al., 1995). 
 Computer surveillance and decision support aids physician decisions by accessing the 
patient’s electronic medical records (eMR). With access to the eMR, a computer 
physician order entry (CPOE) system has the potential to decrease medical costs and 
antibiotic prescribing (Dellit et al., 2007). Progress in this endeavor has been slow.  
However, of particular success has been developed by the Latter Day Saints Hospital in 
Salt Lake City (Burke, J.P., Classen, D.C., Pestotnik, S.L., Evans, R. S., & Steven, 
L.E.,1991). This CPOE system can recommend antibiotic regimens and courses of 
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therapy. It even reviews the patient’s chart for allergies, drug-drug interactions, and 
recommends a dosage (Burke, J, 1991).  A study by Wang and colleagues (Wang, H.Y., 
Lu, C.L., Wu, M.P., Huang, M.H., & Huang, Y.B., 2012) demonstrated that hospitals 
utilizing a CPOE had decreased errors in prescribing compared to hospitals without a 
decision-support system. Another study by Chassin and Galvin, with the Institute of 
Medicine National Roundtable on Health Care Quality examined ways to improve health 
care. One of the main improvements needed was the increased use and quality of CPOE 
(Chassin, M.R. & Galvin, R.W., 1998). Studies have shown that when information 
technology is utilized for treatment decisions, there is a decrease in allergies and adverse 
reactions, length of hospital stay, improper antibiotic prescribing, and antimicrobial cost 
(Evans, R.S., Pestotnik, S.L., Classen D.C., Clemmer, T.P., Weaver, L. K., Orme, J. F. 
Jr…. Burke, J.P., 1998). 
 The Microbiology Lab is also essential to an ASP. The clinical lab plays a critical role 
in an ASP by providing patient-specific culture results and susceptibility data. Accurate, 
expedient results are vital so treatment can be confirmed as correct or altered to optimize 
individual antimicrobial therapy. 
Bacterial resistance has been developing since antibiotic therapy began.  This resistance 
has been sustained, even as more antimicrobials were added for treatment. This continued 
relatively unnoticed as drugs to treat infections were still reasonably available. However, now 
that new antibiotics are scarce, many infections have become more difficult and sometimes 
impossible to treat. 
A program is needed to confront this disturbing trend. The judicious use of antibiotics in 
healthcare settings is critically needed. To coordinate such an effort, an ASP can be implemented 
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for appropriate usage of antibiotics, and improved outcomes. As a public health issue, ASP can 

























ASSESSMENT, POLICY, AND ASSURANCE 
Assessment 
 The core public health functions are to identify health problems (Assessment), implement 
policies to address the issues (Policy), and utilize strategies to assure the desired goals are 
achieved (Assurance). These core functions are displayed in Figure 2.1 (Turnock, 2012). 
Although a useful model, there is a limitation in that the model does not show the 
interactions between the separate functions (Turnock, 2012). 
 Assessment is a key to responding to and protecting the public’s health and involves the 
identification of public health problems. This is an ongoing systematic collection and 
analysis of information used to assess the health of the community (i.e.—hospital patients). 
Health status and community needs are assessed utilizing epidemiologic data and other 
studies (Segigmas, 1981). An ASP in hospitals must assess the use of antibiotics and the 
outcomes. As a public health threat, the use of antimicrobials in one hospital affects patients 
in that hospital, other community hospitals, and the community in general because of 
increased antibiotic resistance. Improper antibiotic use causes bacteria to become resistant. 
These bacteria are spread from patient to patient in the hospital and in the community 
increasing resistance. 
 Local health systems strive to protect patients from antibiotic resistant bacteria by means 
of the ASP. While a coordinated approach is needed, a more independent effort is often 
utilized. In a preferred, idealized approach, acute care hospitals, long-term care facilities, and 
nursing homes would be connected to the public health department. This department would 













(Making Health Safer, 2015). This coordinated approach, headed by the local public health 
department, would provide a more comprehensive approach to community safety and protection 
from antibiotic resistance. 
Assessment Measures 
The measure of antibiotic use is essential to assessing the health threat that resistant bacteria 
pose to the hospital community. Increases in antibiotic use combined with the paucity of new 
antimicrobials being discovered or developed makes every prescription of these valuable 
resources very critical. Of concern are the scenarios where treating a simple infection, 
performing life-saving surgery, and the transplanting an organ will no longer be possible because 
the lack of available antibiotics. The risk is real. Antibiotics stewardship is needed to reverse this 
problematic trend. 
 Potential assessment criteria such as antibiotic usage in the hospital or resistant bacteria 
causing infection alert an ASP of problems concerning the amount of antibiotic prescribing and 
inappropriate use. Improper treatment of infections can be evaluated by measures including 
increased MDRO, increased morbidity, and increased mortality due to unnecessary antibiotic 
treatment (including CDI). One example, the inappropriate use of antibiotics to treat normal flora 
collected from urine cultures is not needed in this situation. Timing of prophylactic treatment for 
surgical procedures is another area in need of revising. Ideally, the antibiotic used for 
prophylaxis should be concentrated at the incision site and delivered properly, approximately 15 
minutes before surgery (Dellit et al., 2007). If not executed correctly, bacterial resistance may 
occur in the patient (Dellit, et al., 2007). Proper use of antibiotics can greatly decrease 
unnecessary antibiotic treatment, thus keeping valuable antibiotics from becoming resistant. 
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 In 2013, the CDC published an article outlining the 17 biggest threats to the public’s 
health in the U.S. due to antibiotic resistance (Antibiotic Resistance Threats in the United States, 
2013). Some of these threats have existed for decades or more and are still a major concern, 
while others are emerging problems. These 17 threats show how extensive the problem of 
antibiotic resistance is, and how essential antibiotic stewardship has become to the health of the 
public (See Table 2.1). 
Of the bacteria on the CDC’s antibiotic resistance list, there are a few bacteria that are a 
threat to public health but are not a direct threat in hospital patients and other medical care 
facilities.  A summary of the more prevalent resistant bacteria found in health care settings and 
under the guidance of the ASP are listed below. 
Urgent Healthcare Threats 
C. difficile 
 Causes life-threatening diarrhea 
 Excess antibiotics destroy normal flora of the gastrointestinal tract 
 250,000 infections per year in the US requiring hospitalization  
 14,000 deaths annually 
 Deaths have increased 400% from 2000 to 2007 
 Almost half of all infections occur in people less than 65 years old, but 90% of deaths 
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Carbapenem-resistant Enterobacteriacea (CRE) 
 Increases seen in patients in medical facilities 
 Resistant to nearly all known antibiotics 
 Resistant to carbapenem, the antibiotic of last resort 
 9,000 Healthcare Associated Infections are caused by CRE each year 
 600 deaths per year are caused by CRE 
Multi-drug resistant Acinetobacter 
 Causes pneumonia and bloodstream infections among critically ill patients 
 Some strains resistant to most available antibiotics; 63% resistant to 3 classes of 
antibiotics 
 12,000 Acinetobacter antitratus infections occur in the US 
 Almost 7,000 are multidrug resistant 
 About 400 deaths annually are attributed to these infections 
Extended Spectrum β-lactamase (ESBL) producing Enterobacteriacea (ESBL-EB) 
 Nearly 20% of all infections due to Enterobacteriacea are caused by ESBL-EB 
 Patients with bloodstream infections caused by ESBL-EB are 57% more likely to die than 
patients with non-EBBL-EB bloodstream infections 
 26,000 drug resistant Enterobacteriacea occur annually with 1,700 deaths 
Vancomycin-resistant Enterococcus (VRE)  
 Mostly seen in patients receiving treatment for bloodstream, surgical site, and urinary 
tract infections 
 Resistant to vancomycin, an antibiotic of last resort 




 1,300 deaths annually are attributable to VRE 
Multidrug-resistant Pseudomonas aeruginosa 
 Some strains are resistant to nearly all or all available antibiotics 
 About 13% of severe hospital infections are caused by multiple-antibiotic resistant P. 
aeruginosa 
 There are more than 6,700 infections yearly due to multidrug resistant P. aeruginosa 
causing 440 deaths 
Methicillin-resistant Staphylococcus aureus (MRSA) 
 Causes a variety of infections from skin and wound to pneumonia and bloodstream 
infections 
 The CDC estimates that over 80,000 severe MRSA infections occur annually and more 
than 11,000 deaths 
 An unknown number of less severe MRSA infections occur annually 
Drug-resistant Streptococcus pneumoniae  
 Developed resistance to most commonly, and now less frequently used antibiotics 
 Approximately 30% of S. pneumoniae infections are annually to be fully resistant to at 
least one clinically relevant antimicrobial 
 There are 19,000 excess hospitalization annually due to this bacteria and more than 7,000 
deaths 
Drug-resistant Tuberculosis (TB)  
 Multi-drug resistant TB is showing resistance to INH and rifampin, essential first line 
antibiotics 
 Extensively drug-resistant (XDR)-TB is showing resistance to first-line and second-line 
antibiotics (ie—amikacin, kanamycin and capreomycin) 
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 The CDC reported that there were 10,528 cases of TB in the U.S. in 2011 with 10% being 
MDR-TB (Antibiotic Resistance Threats in the United States, 2013).  
When an ASP is implemented, there is a need for assessment of antibiotic resistance.  
Antibiotic resistance is at the point where the number of extensively resistant bacteria is 
increasing (Antibiotic Resistance Threats in the United States, 2013). After years of ignoring this 
problem, an antibiotic stewardship program is desperately needed in hospitals and other 
healthcare settings to alleviate the negative outcomes of overuse and misuse of antimicrobials. 
Policy Development 
Policy development calls for public health to serve the public interest in developing 
comprehensive public health policies (Turnock, 2012) in order to protect and improve public 
safety and health. When the assessment of the health of the population is performed, scientific 
data are collected and analyzed in the form of epidemiologic studies.  Evaluation of the data is 
conducted which may suggest policy revisions or entirely new policies (Rowitz, 2013). 
Assessment evaluates significant public health issues, so policies and programs can be 
formed to address the problem.  A major issue in need of policy development is the increasing 
number of antibiotic resistant bacteria. Numerous microorganisms are developing resistance to a 
number of antimicrobials because of improper use. Many of these organisms are virtually 
untreatable. It is estimated that 20% to 50% of all antibiotics prescribed in U.S. hospitals are 
either inappropriate or unnecessary (Core Elements of Hospital Antibiotic Stewardship Program, 
2015).  
The misuse of antibiotics and the spread of resistance has become a growing public 
health threat. Many bacterial infections, once treated with simple antibiotics are now causing 
life-threatening pneumonia and deadly bloodstream infections. TB, once thought of as virtually 
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extinct from the U.S., is now resistant to many of the first- and second-line treatment agents. 
Many other serious threats from misuse of antimicrobials include adverse drug and allergic 
reactions, and CDI. Two policy initiatives are described concerning these issues. 
CDC Recommendations 
Improvement of antibiotic use is an important public health issue and a national priority 
(White House Forum on Antibiotic Stewardship Convenes Government and Private Sector 
Leaders Committed to Improving Antibiotic Prescribing, 2015). The 2006 CDC and the 
Healthcare Infection Control Practice Advisory Committee (HICPAC) (Siegel, J.D., Rhinehart 
E., Jackson, M. & Chiarello, L., 2006) guideline stated that control of MDRO in healthcare had, 
to that point, not been addressed to any extent. To confront this issue there “must include 
attention to judicious antimicrobial use” (Siegel, et al., 2006). As a result, the “Get smart for 
Healthcare Campaign” in 2009 encouraged healthcare providers, hospital administrators, 
patients, and policy makers to promote more efficient use of antibiotics. This campaign also 
initiated the use of ASPs in acute care hospitals (Get Smart Programs and Observations, 2006). 
In 2013, the CDC promoted improvement of antibiotic use for resistant bacterial threats in 
hospitals and communities in the U.S. (Antibiotic Resistance Threats in the United States, 2013). 
Finally, the document of Hospital Antibiotic Stewardship” (Core Elements of Hospital Antibiotic 
Stewardship Program, 2015) lists the essential elements necessary for a successful ASP. These 
are displayed in Table 2.2. 
There is significant promise of improved antibiotic use due to an ASP. Quality of patient 






Core Elements of an Antibiotic Stewardship Program 
 






Leadership Commitment Dedicating necessary human, financial and information 
technology resources 
Accountability Appointing a single leader responsible for program 
outcomes. Experience with successful programs shows that 
a physician leader is effective 
Drug Expertise Appointing a single pharmacist leader responsible for 
working to improve antibiotic use 
Action Implementing at least one recommended action, such as 
systemic evaluation of ongoing treatment needed after a set 
period of initial treatment (i.e. “antibiotic time out” after 48 
hours) 
Tracking Monitoring antibiotic prescribing and resistance patterns 
Reporting Regular reporting information on antibiotic use and 
resistance to doctors, nurses and relevant staff 
Education Educating clinicians about resistance and optimal 
prescribing 
 





correct antibiotic therapy (Gross, R., Morgan, A.S., Kinky, D.E., Weiner, M., Gibson, G. A., & 
Fishman, N.O, 2001). Significant reduction in hospital rates of CDI (CDC’s Top Ten: 5 Health 
Achievements in 2013 and 5 Health Threats in 2014, 2014, 2015) and antibiotic resistance is due 
to the ASP. However, a study (Levin et al, 2012) in 2014 examined the antibiotic prescribing 
habits of physicians. They reviewed medical records from 183 hospitals and found that antibiotic 
prescribing potentially could be improved by 37.2%. Policies are needed to guide, and 
necessitate the development and utilization of this type of program in all acute care and 
healthcare facilities. 
White House National Action Plan 
In September 2015, the U.S. government and the White House issued the “National 
Action Plan for Combating Antibiotic-Resistant Bacteria” (National Action Plan for Combating 
Antibiotic-resistant Bacteria, 2015). This document is a roadmap to guide the nation in 
confronting this challenge. Its vision is to “work domestically and internationally to prevent, 
detect and control illness and death related to infections caused by antibiotic-resistant bacteria by 
implementing measures to mitigate the emergence and spread of antibiotic resistance and 
ensuring the continued availability of therapeutics for the treatment of bacterial infections.” 
(White House Forum on Antibiotic Stewardship Convenes Government and Private Sector 
Leaders Committed to Improving Antibiotic Prescribing, 2015). Five goals are included in this 
National Action Plan (NAP): 1) slow the emergence of antibiotic resistance; 2) strengthen 
surveillance of resistance bacteria; 3) develop rapid diagnostic tests; 4) increase new antibiotic and 
vaccine development; and 5) collaborate internationally on these issues (White House Forum on 
Antibiotic Stewardship Convenes Government and Private SectorLeaders Committed to 
Improving Antibiotic Prescribing, 2015). 
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Goal 1 of the National Action Plan: slow the emergence of antibiotic resistance.  
Goal 1 of the NAP calls for the direct and essential action to be taken in the judicious use 
of antibiotics. Implementation of an ASP for all medical facilities where the prescribing of 
antibiotics is prominent is recommended. Judicious use of antibiotics in healthcare slows the. 
emergence of resistance and extends the effectiveness of antibiotics. The goal is that each patient 
“receives the right antibiotic at the right time at the right dose for the right duration…”  
(White House Forum on Antibiotic Stewardship Convenes Government and Private Sector 
Leaders Committed to Improving Antibiotic Prescribing, 2015). 
 The significant outcomes of this goal from the NAP 2015 include 1) the establishment of 
an ASP in all acute care hospitals with improved antibiotic stewardship across all healthcare 
settings; 2) reduction of inappropriate antibiotic use by 50% in outpatient settings and by 20% 
for inpatients; and 3) establishment of antibiotic resistance prevention programs in all 50 states 
(White House Forum on Antibiotic Stewardship Convenes Government and PrivateSector 
Leaders Committed to Improving Antibiotic Prescribing, 2015). The utilization of an ASP is 
needed to meet the goals of the National Action Plan and to reduce the increasing public health 
burden of antibiotic resistant bacteria. 
Goal 2 of the National Action Plan: strengthen surveillance of resistance bacteria. 
Improved detection and control of antibiotic resistance is needed. A coordinated effort 
will be able to monitor pathogens for resistance in all hospitals, eventually branching out to other 
healthcare settings. These activities will monitor the usage of antimicrobials and their resistance 
patterns, thus enhancing surveillance. 
Goal 3 of the National Action Plan: develop rapid diagnostic tests. 
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Rapid detection of resistant bacterial infections enhances treatment by decreasing 
inappropriate antibiotic use. An expedited response from the microbiology lab provides more 
optimal treatment decisions. Classic microbiology cultures have at least a two-day lag-time 
before results are finalized. However, rapid, nucleic acid-based tests provide results in only 
hours. (Dellit, et al., 2007) Use of these quicker testing procedures, and research to develop even 
more efficient ones, is greatly needed to enhance ASP efforts. 
Goal 4 of the National Action Plan: increase new antibiotic and vaccine development. 
There is an urgent need for new antibiotics. Currently, there are few new antibiotics in 
the pipeline. Advancement of drug development is in need from scientific research to generate 
new antibiotics. Incentives are proposed for research in the development of antibiotics. Clinical 
trials to test their efficacy and safety are also need. These trials must be made more efficient to 
expedite the introduction of new antibiotics for therapy 
Goal 5 of the National Action Plan: collaborate internationally on these issues.  
Antibiotic resistance is not only a problem in the U.S., it is an international problem. No 
nation, including the U.S. is isolated from resistant bacteria. Thus, ASPs are needed worldwide. 
To that end, the World Health Organization has developed a program to enhance the detection, 
analysis, and reporting of antimicrobial use and resistance. (White House Forum on Antibiotic 
Stewardship Convenes Government and PrivateSector Leaders Committed to Improving 
Antibiotic Prescribing, 2015) The U.S. supports this international collaboration in the fight 
against antibiotic resistance. 
Assurance 
Assurance, the third core function of public health, ensures that services are delivered.  
Once an action plan has been initiated, assurance is utilized to ensure that a program is 
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implemented as planned. Lastly, the program is evaluated for effectiveness and whether it needs 
to be reformed or redirected (Turnock, 2012). 
Measures (usually epidemiologic) are used to analyze data concerning the outcome. For 
antibiotic stewardship, there are a myriad of measures to evaluate the amount of antibiotic use in 
hospitals, the amount of antibiotic resistance, and clinical outcomes. The amount of antibiotic 
use is calculated by two measures: either days of therapy (DOT) or defined daily dose (DDD). 
DOT is the sum of days any amount of a specific antibiotic is administered to a patient divided 
by patient days in the hospital (Core Elements of Hospital Antibiotic Stewardship Program, 
2015). On the other hand, DDD is the amount of drug delivered to the patient divided by a 
standard developed by the World Health Organization (Core Elements of Hospital Antibiotic 
Stewardship Program, 2015). Examples of calculations are shown in table 2.3. Other 
measurements include total hospital antibiotic use, targeted antibiotic use, and duration of 
therapy. 
One way to measure the impact of antibiotic stewardship is by focusing on patients who 
recovered from antibiotic-resistant infections. These patients, under the influence of an ASP, are 
monitored to assess the percentage of patients who recovered from all hospital infections, the 
percentage of patients who developed a “super” infection, and those who died from the infection. 
Clinical outcomes are a major measure of assurance for antimicrobial usage. With 
changing therapy recommended by the ASP, measures are needed to assure physicians that 
replacing an antibiotic for one preferred by the ASP is clinically efficacious, safe, and preserves 
valuable antimicrobials. Clinical outcome measures for this purpose include all-cause mortality, 
infection-related mortality, duration of hospitalization, and rate of readmission (Kollef, M.H. & 




Examples of Defined Daily Dose and Days of Therapy Calculations  
Define Daily Dose (DDD) 
Calculation of yearly rates 
Annual amount of antibiotics dispensed in 1996: 
   26,916,839 DDD 
Population (from Census): 3,959,698 
   26916839 DDD/3,959,698 = 6.80 DDD/inhabitant-year 
   6.80 x 1000/365 = 18.63 DDD/1000 inhabitant-days 
Days of Therapy 
 
2009 Pharmacy drug budget of $3,000,000  
Antimicrobial acquisition costs $750,000 (25% of budget)  
 
Cost savings (percent reduction in antimicrobial costs):  
 
a) overall antibiotic acquisition costs  
2010 $750,000  
2011 $675,000  
 
Absolute decrease of $75,000, equals 10% reduction  
 
b) ICU antibiotic acquisition costs  
2010 $100,000 (patient days = 2000, $50/patient-day)  
2011 $75,000 (patient days = 2000, $37.50/patient-day)  
 
Absolute decrease of $25,000, equivalent to a reduction of $12.50/patient-day  
 





sometimes cannot be sufficiently powered as larger studies are needed. These larger studies will 
ensure the validity of the intervention. 
 Microbiologic outcomes can also demonstrate the validity of an ASP. This can be 
measured by the percentage of organisms resistant to a certain antibiotic, the percentage of drug-
resistant organisms, or the number of infections due to a particular drug-resistant organism 
(MacDougal, C. & Polk, R.E., 2005). However, there are other factors attributable to ASPs that 
can affect resistance. The rate of isolation of resistant bacteria in the selection of antimicrobials, 
duration of therapy, and dosage of specific antibiotics can all be a factor. These all affect 
resistance patterns. However, in spite of the desire to associate microbiology data and resistance, 
inferring patient improvement with microbiological results can be inaccurate (Phillips, 2001). 
A study by Ansari and colleagues (Ansari, F., Gray, K., Nathwani, S., Ogston, S., 
Ramsay, C. & Davey, P., 2003) examined various endpoints of an ASP for changes in 
antimicrobial usage and antibiotic resistance to test the program’s effectiveness in the hospital. 
The study analyzed multiple time points prior to and subsequent to the initiation of the 
stewardship program. Figure 2.2 displays a graph of the results of the study with outcomes 
(shown on the y-axis) and time before and after intervention (on the x-axis). This depicts an 
increase in antibiotic use and resistance, and shows an increasing slope before antibiotic 
stewardship intervention. The graph also displays an extrapolated (dashed) line which depicts the 
situation had the intervention not been started. At the point of initiating antibiotic stewardship, a 
gradual decrease in the line’s slope illustrates a reduction in antibiotic use and resistance. From 
the data of antibiotic use and antibiotic resistance, a significant decrease in the slope is a positive 
sign of the effectiveness of an ASP. These results exemplify how measuring key outcomes can 
assure the success of an ASP. 
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Figure 2.2 
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Assurance determines the fate of an intervention. Outcomes of assurance can recommend a 
continuation of the program with potential minor changes, complete program revamping, or the 
end of the program. Assurance compares what is needed to what is delivered by a program. It is a 
valuable evaluation of an ASP. Ineffective public health programs waste valuable monetary 
resources, and lead to diminished health and increased mortality. 
 Increased antibiotic resistance is a growing public health issue and ASPs in hospitals are 
necessary to reverse this alarming trend.  Measurements to analyze successes and failures are  
required for the ultimate accomplishments of the program. The amount of antibiotics used, 
recovery from infection, clinical outcomes, and microbiological outcome can be measured. 
However, the results of each outcome measure can have varying validity. Use of these measures 
assures that the antibiotic stewardship program is performing appropriately. 
As shown by the variety and increasing number of urgent and serious bacterial threats to 
our health, a concerted effort is needed by all hospital personnel, under the guidance of the ASP, 
to prevent the continued rise in antibiotic resistance.  Monitoring and directing antibiotic therapy, 
the main mission of an ASP, is needed to assure healthy patient outcomes and reduced antibiotic 






LEADERSHIP, EDUCATION, AND FUTURE RESEARCH 
Leadership 
 Leadership is critically needed for the success of an ASP. The leaders must be dedicated 
to the program interventions and can contribute in a number of ways. Leadership can issue 
formal statements supporting the efforts of the ASP to improve and monitor antibiotic usage. 
Leaders can add antibiotic stewardship-related duties to job descriptions and annual performance 
reviews to encourage compliance by clinical personnel. Staff in departments relevant to 
antibiotic stewardship should be given sufficient time to implement activities of the program 
(Core Elements of Hospital Antibiotic Stewardship Program, 2015). Also, support for training 
and education should be provided. Besides these, the dedication of financial, human, and IT 
resources to the ASP greatly enhances its effectiveness (Core Elements of Hospital Antibiotic 
Stewardship Program, 2015). For any ASP to succeed, support from the administration is crucial. 
 Program funding, institutional policy, and physician autonomy are issues that must be 
addressed by hospital leaders in the development of an ASP. The duty of administrators is to 
deliver answers to these critical issues. Funding of the program is an absolute must for the 
initiation and continuation of the ASP. Infectious disease doctors and clinical pharmacists must 
be compensated, and information technology must be kept up-to-date. However, leadership can 
show how these expenses can be covered by the savings procured by activity of the stewardship 
program that reduce hospital expenses. 
 Physician autonomy for prescribing in the past has allowed physicians to use the 
antibiotic of their choice to treat an infection. Policies are needed to change this, and the 
antibiotic prescribing habits of physicians via ASPs. Administration needs to enact this policy or 
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physicians will continue inappropriate antibiotic therapy, derailing the ASP (Dellit, et al., 2007) 
and extending the perilous cycle of antibiotic resistance. 
Education 
The CDC offers many documents and websites concerning antibiotic-resistant bacteria 
and ASPs. These documents advise the initiation of an ASP and the continuation of that 
program.  Descriptions of antibiotic–resistant threats to hospital patients are available. The U.S. 
government has also issued a policy paper that emphasizes goals to be met concerning resistant 
bacteria (White House Forum on Antibiotic Stewardship Convenes Government and 
PrivateSector Leaders Committed to Improving Antibiotic Prescribing, 2015). 
 In addition to the CDC information about resistance and ASPs, there is a need for more 
education of physicians, other healthcare providers, and hospital staff about antibiotics 
stewardship (Core Elements of Hospital Antibiotic Stewardship Program, 2015). Healthcare 
providers must be enlightened about their contributions to the problem of antibiotic resistance. 
Old prescribing habits must be broken, and new, improved antibiotic treatments that decrease the 
chance of resistance must be adopted hospital-wide. However, education alone, without the 
acceptance of formulary restriction or preauthorization interventions, shows minimal effect 
(Dellit et al., 2007). 
 Regular updates about antibiotic prescribing and antibiotic resistance should be provided 
to inform the clinical staff about state and national trends in antibiotic resistance (Core Elements 
of Hospital Antibiotic Stewardship Program, 2015). Facility-specific results are also analyzed 
and then shared with pertinent hospital personnel. There are other forms of education concerning 
resistance and ASPs that can be utilized. Presentations in formal and informal settings provide a 
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means to further promote stewardship intervention. Posters, flyers, newsletters, and electronic 
communication are other effective means of educating about antibiotic issues. 
 Another reason why education is needed for prescribing and antibiotic resistance is the 
limited time medical schools spend teaching about infectious diseases or the antibiotics to treat 
infections (MacDougal, C. & Polk, R.E., 2005). Consequently, what physicians learned on these 
subjects has been gleaned from colleagues, antibiotic handbooks, and pharmaceutical sales 
representatives (MacDougal, C. & Polk, R.E., 2005). Also, most physicians are cognizant of the 
antibiotic resistance issue that exists; however, they underestimate the true scope of the problem, 
especially in their own facility (MacDougal, 2005) With limited knowledge of antibiotic 
resistance, physicians and other health care providers may be open to education about remedies 
to this issue and the value of an ASP. 
Future Research 
 Antibiotic stewardship is a relatively young discipline. Thus, there are many areas of 
research that can improve the outcomes. One area that needs study involves the two primary 
forms of intervention: formulary restriction and preauthorization or prospective audit with 
intervention and feedback. A determination is needed as to which active intervention generates 
the best results to decrease antibiotic resistance in hospitals. 
 Along with primary interventions, supplemental strategies are also utilized in ASPs. 
These strategies, such as guidelines and clinical pathways and computer surveillance and 
decision support will always need improvement to enhance their capability. These interventions 
can only be executed with IT support. Research is needed to further develop these systems to 
better serve ASPs needs to perform these interventions. Other secondary interventions also need 
studied to determine if they can be improved, and better complement primary interventions 
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effectively. Both primary and secondary interventions can be utilized as ASP strategies. Alone, 
secondary interventions are not nearly as successful as a primary intervention. However, both 
primary and secondary strategies, when implemented together, are more effective. Research is 
needed to elucidate which of the primary and secondary strategies when implemented together, 
yield the most successful results. 
 ASPs were initially implemented in adult healthcare settings. Research is needed to better 
utilize ASP effectiveness in other different healthcare settings. Hospitalized children are an area 
of concern. Many children’s hospitals are implementing or developing an ASP (Newland, J.G., 
Gerber, J.S., Weissman, S.S., Shah, S.S., Turgeon, C., Hedican, E.B….& Hersh, A.L, 2015). 
Analysis of the ability of an intervention to produce positive outcomes and reduce antibiotic 
resistance in settings other than adult health care requires further investigating. 
 Institutional policies are needed to establish ASPs in the hospital. Leadership support 
from the hospital administration is necessary for the success of the policy for these programs. 
Education, a supplemental strategy of antibiotic stewardship, supports the advancement of ASPs, 
and can fill in the gaps in clinical personnel knowledge of prescribing antibiotics and bacterial 
resistances. 
  Research on primary and secondary interventions of an ASP is necessary to establish 
which ones are more successful, and which combinations can be established as effective. The 
efficacy of ASP in outpatient situations needs to be researched. Nonetheless, antibiotic 
stewardship will always require research for advancement of the program so it can continue to 






CONCLUSIONS AND RECOMMENDATIONS 
 The three core functions of public health ultimately direct interventions for the betterment 
of the health of the community and the nation. Assessment, the first of the core functions, has the 
role of discovering the health needs of the public. Using a variety of tools and depending upon 
the health issue, public health problems are exposed from the data uncovered by assessment. 
Assessment directs policy development. Policies are then formulated and supported by the 
assessment results and community needs. In the policy development step, programs are formed 
to address the issues. These programs are subsequently evaluated to assure they are delivering 
what the policy promises. The end results of the assurance step can decide the fate of the 
program, whether to continue with the status quo, create changes, or reassess the health issue. 
 Antibiotic resistance has been shown to be a public health threat for many years, perhaps 
naively ignored. Since the beginning of antibiotic treatment, bacteria have evolved and resistance 
has occurred. Subsequent introduction of other antibiotics have exhibited the same results. By 
the 1970s, S. aureus, an invasive bacteria, became resistant to methicillin and other similar 
drugs, and gram negative bacteria (i.e.—E. coli, K. pneumoniae)started to become resistant to 
multiple drugs. By the mid-1990s, Enterococci were resistant to vancomycin, a drug of last 
resort. By the early 2000s, there was a significant rise in the number of concerning drug resistant 
organisms, and today where several bacteria are now becoming untreatable by any of the 
available drug treatments. 
 With significant increases in antibiotic resistance, a public health intervention was 
necessary to stop this surge of antibiotic resistance. Appropriate use of antibiotics was the 
answer. For this, hospitals initiated an ASP to restrict improper antibiotic use. Data from these 
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initial studies of antibiotic stewardship showed a significant decrease in antimicrobial use and 
inappropriate prescribing. Other metrics also displayed a favorable assessment of stewardship. 
Hospital policies followed. Then, in 2014, the U.S. government and the White House developed 
the “National Action Plan for Combating Antibiotic-resistant Bacteria” with the goal of 
decreasing resistant bacteria. The primary goal of this policy is the establishment of an ASP in 
all hospitals and other medical facilities nationwide. 
The CDC offers many documents and websites concerning antibiotic-resistant bacteria 
and ASP. These documents provide guidance for the initiation of an ASP and the continuation of 
that program.  Descriptions of antibiotic–resistant threats to hospital patients are available. The 
U.S. government has also issued a policy paper that emphasizes goals to be met concerning 
resistant bacteria. 
A public health intervention assesses community health issues, develops policies to 
remedy the issue, and assures effective outcomes of a program. These are the three core 
functions of Public Health. These can be used to analyze antibiotic stewardship response to 
antibiotic resistance. This process ensures proper antibiotic use with a clear decrease in antibiotic 
resistant bacteria.  
ASP is the answer to antibiotic resistance. The Core Functions of Public Health—
Assessment, Policy Development and Assurance—show how effective antibiotic stewardship 
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